# 摘要

| Ref | Title | Summary |
| --- | --- | --- |
| [^1] | [A Mean-Field Game of Market Entry: Portfolio Liquidation with Trading Constraints](https://arxiv.org/abs/2403.10441) | 研究了带有交易约束的投资组合清算的均场博弈，证明了均衡交易率可通过高度非线性积分方程求解，并证明了均衡存在且唯一。 |
| [^2] | [The Impact of Acquisitions in the Biotechnology Sector on R&D Productivity.](http://arxiv.org/abs/2203.12968) | 本研究发现，在生物技术行业的收购中，收购导致发明家的留任率下降，引用加权专利生产力下降。留在收购公司的发明家的产品性能下降更为严重，尤其是那些专业知识与目标公司密切相关的发明家。然而，年长的发明家和专业知识与收购公司现有的研发组合相符的发明家在收购后保持了较高的生产力水平。 |

# 详细

[^1]: 市场准入的均场博弈：带有交易约束的投资组合清算

    A Mean-Field Game of Market Entry: Portfolio Liquidation with Trading Constraints

    [https://arxiv.org/abs/2403.10441](https://arxiv.org/abs/2403.10441)

    研究了带有交易约束的投资组合清算的均场博弈，证明了均衡交易率可通过高度非线性积分方程求解，并证明了均衡存在且唯一。

    

    我们考虑了涉及$N$个玩家的最优投资组合清算的博弈和均场博弈，在这些博弈中，玩家不被允许改变交易方向。初始空头头寸的玩家只能买入，而初始多头头寸的玩家只能卖出股票。在模型参数合适的条件下，我们证明了这些博弈等价于需要确定最佳市场准入和退出时间的定时博弈。我们确定了均衡的准入和退出时间，并证明了均衡的交易率可以通过以端点条件为内生条件的高度非线性高阶积分方程的解来表征。我们证明了积分方程存在唯一解，由此我们得出了均场和$N$个玩家博弈中均衡存在且唯一的结论。

    arXiv:2403.10441v1 Announce Type: new  Abstract: We consider both $N$-player and mean-field games of optimal portfolio liquidation in which the players are not allowed to change the direction of trading. Players with an initially short position of stocks are only allowed to buy while players with an initially long position are only allowed to sell the stock. Under suitable conditions on the model parameters we show that the games are equivalent to games of timing where the players need to determine the optimal times of market entry and exit. We identify the equilibrium entry and exit times and prove that equilibrium mean-trading rates can be characterized in terms of the solutions to a highly non-linear higher-order integral equation with endogenous terminal condition. We prove the existence of a unique solution to the integral equation from which we obtain the existence of a unique equilibrium both in the mean-field and the $N$-player game.
    
[^2]: 生物技术领域收购对研发生产力的影响

    The Impact of Acquisitions in the Biotechnology Sector on R&D Productivity. (arXiv:2203.12968v2 [econ.GN] UPDATED)

    [http://arxiv.org/abs/2203.12968](http://arxiv.org/abs/2203.12968)

    本研究发现，在生物技术行业的收购中，收购导致发明家的留任率下降，引用加权专利生产力下降。留在收购公司的发明家的产品性能下降更为严重，尤其是那些专业知识与目标公司密切相关的发明家。然而，年长的发明家和专业知识与收购公司现有的研发组合相符的发明家在收购后保持了较高的生产力水平。

    

    本研究使用1990年至2010年间收集的15,318名发明家参与了1,375次收购的数据，研究了收购对生物技术行业发明家的留任率和研发生产力的影响。我们采用跨时差异法，并发现收购导致发明家的留任率下降13.5%，引用加权专利生产力下降35%。对于留在收购公司的发明家，产品性能下降的更为严重，尤其是那些专业知识与目标公司密切相关的发明家。然而，年长的发明家和专业知识与收购公司现有的研发组合相符的发明家在收购后保持了较高的生产力水平。

    This study examines the effects of acquisitions on the retention and R&D productivity of inventors in the biotech sector, using data from 15,318 inventors involved in 1,375 acquisitions between 1990 and 2010. We employ a staggered difference-in-differences approach and find that acquisitions lead to a 13.5% decrease in inventor retention and a 35% drop in citation-weighted patent productivity post-acquisition. The productivity decline is more severe for inventors who remain with the acquiring firm, particularly for those whose expertise is closely tied to the target company. However, older inventors and those whose expertise aligns with the acquiring company's existing R&D portfolio tend to retain higher productivity levels after the acquisition.
    

